Ress Life Investments A/S
Ress Life Investments A/S announces capital increase
Ress Life Investments A/S announces capital increase
Ress Life Investments A/S
Nybrogade 12,
1203 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 27 February 2025
Corporate Announcement 07/2025
Ress Life Investments A/S announces capital increase.
The Board of Directors in Ress Life Investments A/S has today resolved to utilise its authorisation in article 4.8 of the articles of association to increase the company's share capital with nominally EUR 96,000 by issuance of 192 new shares with a nominal value of EUR 500 each at a price of EUR 2496.32 per share of EUR 500 without pre-emption rights for the company's existing shareholders.
After the capital increase, the registered share capital of the company is EUR 87,873,500 divided into 175,747 shares of EUR 500 nominal value each. Each share of nominal EUR 500 carries one vote at general meetings in Ress Life Investments A/S.
The new shares will be admitted for trading and official listing on NASDAQ Copenhagen A/S under the same ISIN code as the company's existing shares.
Updated articles of association of the company are attached.
Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@resscapital.com
Tel + 46 8 545 282 27
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Realkredit Danmark A/S17.6.2025 11:15:29 CEST | Press release
Realkredit Danmark A/S publishes new Base Prospectus for mortgage covered bonds and mortgage bonds
Spectra Aerospace & Defense17.6.2025 11:00:00 CEST | Press release
Galleon Embedded Computing Successfully Recertified for ISO/IEC 27001, Reinforcing Its Commitment to Information Security
EVERZOM17.6.2025 11:00:00 CEST | Press release
Winner of the “Biotherapies and Bioproduction” call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its exosome bioproduction technology
Sveriges Riksbank17.6.2025 10:15:00 CEST | Press release
RESULT OF RIKSBANK CERTIFICATE SALE
Sveriges Riksbank17.6.2025 10:05:00 CEST | Press release
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom